Vendor Qualification Is Not Vendor Oversight

Most sponsors do vendor qualification well. There’s a questionnaire, an audit, a quality agreement, and a signed-off file that says the vendor is approved. Then the study starts, and for many programs that is where the attention stops.

But qualification tells you a vendor was capable on the day you assessed them. Oversight tells you whether they are still performing throughout the trial. Regulators expect both, and they inspect the second one much more closely than most teams expect.

Why the gap matters

Sponsors can delegate tasks to vendors, but they cannot delegate responsibility. When an inspector finds a problem with a CRO, a central lab, an imaging provider or an eCOA system, the question is rarely “was this vendor qualified?” It is “what did the sponsor do when they saw the signal?”

A qualification file from two years ago doesn’t answer that question. An oversight record does.

Signs you have qualification but not oversight

• The audit was a one-time event. The vendor was audited before contract signature and never looked at again, even after staff turnover, system upgrades or a change in scope.
• Quality agreements sit in a folder. Roles and responsibilities were defined on paper, but no one checks whether they are being followed.
• Metrics are collected but not acted on. KPIs and KRIs are reported, yet no one documents the trend, the decision or the follow-up.
• Issues are handled informally. Problems are resolved over email or calls without deviation tracking, CAPA or escalation, so there is no evidence of control.
• Critical vendors are treated like all others. The vendor handling your primary endpoint gets the same light-touch oversight as a low-risk supplier.

Focus first on critical endpoints

Not every vendor deserves the same level of scrutiny. The ones that need it most are those that touch primary endpoints, patient safety and data integrity: imaging, central labs, IRT, EDC, eCOA and similar systems. In oncology and hematology trials, where endpoint assessment can be complex and highly dependent on consistent processes, weak oversight here can put an entire submission at risk. Critical endpoints deserve critical oversight.

What effective oversight looks like

• Risk-based planning. Decide up front which vendors are critical and set oversight intensity accordingly.
• Ongoing, not one-off. Use periodic and for-cause audits, and reassess when something changes.
• Defined metrics with real decisions. Track performance, document trends and record what you did about them.
• Clear escalation paths. Deviations and quality issues should move quickly to a documented CAPA with follow-through.
• Oversight that can be explained. Your team should be able to tell the story of how the vendor was controlled, and answer confidently when an inspector asks.

The takeaway

Qualification opens the door. Oversight is what shows you stayed in control. If your vendor management stops at approval, you have a good starting file but not a defensible oversight program.

Not sure where your vendor oversight would stand up to an inspector? Talk to the VedX Clinical team about an independent vendor and system audit at vedxclinical.com.